SCYNEXIS Inc. | Ownership
Companies that own SCYNEXIS Inc.
Federated Global Investment Management Corp.
6,868,400
14.66%
0
0.07%
06/30/2018
Caxton Corp.
2,955,000
6.31%
-1,915,409
4.01%
06/30/2018
Broadfin Capital LLC
1,885,904
4.03%
0
0.35%
06/30/2018
The Vanguard Group, Inc.
1,837,179
3.92%
173,086
0%
06/30/2018
DAFNA Capital Management LLC
1,275,527
2.72%
-361,373
0.67%
06/30/2018
Rock Springs Capital Management LP
820,000
1.75%
0
0.04%
06/30/2018
Granite Point Capital Management LP
678,450
1.45%
0
0.37%
06/30/2018
Geode Capital Management LLC
470,130
1%
341,406
0%
06/30/2018
Iguana Healthcare Management LLC
400,000
0.85%
150,000
0.35%
03/31/2018
National Asset Management, Inc.
344,245
0.74%
61,305
0.06%
03/31/2018
| Address |
1 Evertrust Plaza
Jersey City New Jersey 07302
United States
|
|
Employees
|
- |
| Website |
http://www.scynexis.com |
| Updated |
07/08/2019 |
| SCYNEXIS, Inc. engages in the development and commercialization of novel anti-infectives, which addresses the significant unmet therapeutic needs. It develops a novel oral and intravenous drug for several fungal infections, including serious and life-threatening invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. |
